Cargando…
Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies
The gut microbial dysbiosis is a risk of colorectal cancer (CRC) and some bacteria have been reported as potential markers for CRC diagnosis. However, heterogeneity among studies with different populations and technologies lead to inconsistent results. Here, we investigated six metagenomic profiles...
Autores principales: | Zhang, Huarong, Wu, Junling, Ji, Daihan, Liu, Yijuan, Lu, Shuting, Lin, Zeman, Chen, Ting, Ao, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668862/ https://www.ncbi.nlm.nih.gov/pubmed/36406447 http://dx.doi.org/10.3389/fmicb.2022.1005201 |
Ejemplares similares
-
Metabolism-Related Gene Pairs to Predict the Clinical Outcome and Molecular Characteristics of Early Hepatocellular Carcinoma
por: Wu, Junling, et al.
Publicado: (2022) -
Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer
por: Feng, Jiahui, et al.
Publicado: (2023) -
Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
por: Zhang, Huarong, et al.
Publicado: (2023) -
Editorial: Microbial advances towards sustainable environment: Microbiome structure & integrated technologies
por: Salama, El-Sayed, et al.
Publicado: (2022) -
Emerging microfluidic technologies for microbiome research
por: Yu, Yue, et al.
Publicado: (2022)